1. Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target

   • Yura Son
   • Wuqiang Zhu

   Current Opinion 13 December 2022 Pages: 129 - 140

   

2. Candidate MicroRNA Biomarkers in Lupus Nephritis: A Meta-analysis of Profiling Studies in Kidney, Blood and Urine Samples

   • Amir Roointan
   • Alieh Gholaminejad
   • Yousof Gheisari

   Systematic Review 15 December 2022 Pages: 141 - 158

   

3. Emerging Landscape of SARS-CoV-2 Variants and Detection Technologies

   • Xianghui Li
   • Jing Wang
   • Hu Wang

   Review Article 28 December 2022 Pages: 159 - 177

   

4. Progress in Clinical Gene Therapy for Cardiac Disorders

   • Francisco J. Romeo
   • Spyros A. Mavropoulos
   • Kiyotake Ishikawa

   Review Article 15 January 2023 Pages: 179 - 191

   

5. The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics

   • Dhaneshree Bestinee Naidoo
   • Anil Amichund Chuturgoon

   Review Article 19 January 2023 Pages: 193 - 226

   

6. The Role οf Ion Channels in the Development and Progression of Prostate Cancer

   • Minas Sakellakis
   • Athanasios Chalkias

   Review Article 04 January 2023 Pages: 227 - 242

   

7. Introducing Circulating Vasculature-Related Transcripts as Biomarkers in Coronary Artery Disease

   • Hoda Y. Abdallah
   • Ahmed Fareed
   • Loaa A. Tag El Deen

   Original Research Article Open access 20 December 2022 Pages: 243 - 259

   

8. Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach

   • Ruben D. Houvast
   • Maurice van Duijvenvoorde
   • Peter J. K. Kuppen

   Original Research Article Open access 19 January 2023 Pages: 261 - 273

   

9. Systematic In-Silico Evaluation of the Diagnostic Impact of Mpox Genome Variants in the Current Outbreak

   • Aastha Vatsyayan
   • V. R. Arvinden
   • Vinod Scaria

   Short Communication 10 December 2022 Pages: 275 - 280

   

10. Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab

    • Tobin J Cammett
    • Katherine Garlo
    • Susan J. Faas

    Correction Open access 04 March 2023 Pages: 281 - 281